Go Symbol Lookup
Loading...

Cramer's Top 5 Dividend Stocks

 Text Size  
Published: Wednesday, 30 May 2012 | 6:31 PM ET
By:

Producer

Abbott Laboratories (ABT)

Abbott Labs

Drug manufacturer Abbott Laboratories currently boasts a 3.3 percent dividend yield. The Abbott Park, Ill.-based company has increased its payout at a 14 percent compound annual clip since 1980, too.

Abbott plans to split into two companies later this year with the branded drugs business going by the name AbbVie. Cramer likes both businesses and will decide which he prefers as the split draws near.

Read on for more of Cramer's Top 5 Dividend Stocks.

Pepsico (PEP)

Pepsi

Those thirsting for dividends should check out Pepsico’s 3.1 percent dividend yield. The food and beverage maker has increased its dividend by 12 percent annually for the last 32 years, Cramer said.

“Pepsi’s a classic turnaround story, but the turn is only just beginning to become obvious,” Cramer said. “I think it’s working, but you’re being paid handsomely to wait until everyone knows it.”

Not only is Pepsi currently benefiting from lower raw costs, it also has less international exposure than rival Coca-Cola.

Read on for the last of Cramer's Top 5 Dividend Stocks.

Target (TGT)

 Print
Find out which stocks made his dividend-paying portfolio.
  Price   Change %Change
ABT ---
ED ---
KO ---
PEP ---
SHW ---
TGT ---
WMT ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p | 11p ET
  • Cramer is host of CNBC's "Mad Money," and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.